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rophages and can affect disease development such as IBD.4 
Although there is a prior study using trinitrobenzene sulfon-
ic acid-induced colitis and focusing on succinate receptor 1 
(SUCNR1) and fibrosis,5 it is not yet clear whether succinate 
directly affects macrophage activity in colitis. Wang et al.6 showed 
macrophages from peritoneal cavity cells (PCCs) affect exper-
imental colitis. Hence, to identify the direct effect of succinate 
on macrophages, we performed a transfer experiment to find 
out the effects of succinate on macrophages in a dextran sul-
fate sodium (DSS) (MP Biomedicals, Solon, OH, USA)-induced 
colitis model (Fig. 1A). All experiments using animals were re-
viewed and approved by the Institutional Animal Care and 
Use Committee of Yonsei University Severance Hospital (IA-
CUC No: 2018-0227), and all methods were performed in ac-
cordance with relevant guidelines and regulations. Eight-week-
old male C57BL/6 mice were maintained in 12 hours light/12 
hours dark cycle at 22°C under specific pathogen‐free condi-
tions and used as donors of peritoneal macrophages. The fol-
lowing groups of mice were used as donors: injected vehicle 
(Veh) (n = 4); injected succinate (Suc) (n = 4). F4/80+ peritoneal 
macrophages were isolated using BD FACS Aria II (BD Biosci-
ences, San Jose, CA, USA) from the collected peritoneal cells 
of mice which were then intraperitoneally injected with 40 
mM succinate or not for 3 days (Fig. 1B and C). Isolated F4/80+ 
cells of 2 × 105 were intraperitoneally injected to recipient mice 
in 200 μL Hanks’ balanced salt solution (HBSS; Thermo Fisher 
Scientific, Inc., Waltham, MA, USA) (day 0) and the mice were 
sacrificed after 2% (wt/vol) DSS in drinking water until day 6 
followed by normal water administrated for 2 days. Recipient 
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BRIEF COMMUNICATION
Inflammatory bowel disease (IBD), which includes Crohn’s 
disease and ulcerative colitis, is a chronic and inappropriate 
inflammatory disorder of the intestine. It is considered that in-
teractions between genetic factors, microbiota, and host im-
mune system are involved in the pathogenesis of IBD. Particu-
larly, recent studies have shown that metabolites from intesti-
nal microbes or host modulate the immune system in colitis.1 
This study focused on macrophages and the role of succinate 
as an anti-inflammatory metabolite in IBD. Macrophages exist 
in almost all organs and are responsible for the first line of an-
timicrobial defense.1 The macrophages can be divided into 
pro-inflammatory M1 macrophages, called “classical macro-
phage,” and anti-inflammatory M2 macrophages, called “alter-
native macrophage.” It was reported that switching between 
M1 and M2 macrophages occurs through metabolic changes. 
In M2 macrophages, the succinate is oxidized to fumarate, re-
sulting in electron transport chain flow that provides energy 
for adenosine triphosphate synthase. On the other hand, re-
verse electron transport occurs and succinate is accumulated 
in M1 macrophages.2,3 If the polarization of macrophages is 
not properly regulated, this increases the proportion of M1 mac-
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groups were as follows: water, administered with normal water 
(n = 3); DSS+HBSS, administered with HBSS (n = 6); DSS+Veh-
PCC, recipients of PCC (n = 4); DSS+Suc-PCC, recipients of 
PCC treated succinate (n = 4). To estimate the severity of coli-
tis, body weight, and disease activity index (DAI) were checked 
daily. The DAI scores, which ranged from 0 to 4, were calculat-
ed using the following parameters: body weight loss (0, none; 
1, 1%–5%; 2, 5%–10%; 3, 10%–20%; 4, > 20%), stool consistency 
(0, negative; 1 and 2, loose; 3 and 4, diarrhea), and bleeding (0, 
absence; 1 and 2, slightly bleeding; 3 and 4, bloody).7 The calcu-
lated formula was as follows: DAI = (body weight loss score)+ 
(stool consistency score)+(bleeding score). The colon length 
was measured between the ileocecal junction and the proxi-
mal rectum.
DSS+Suc-PCC mice showed the attenuated body weight loss 
(Fig. 2A), DAI (Fig. 2B), and a colon length shortening (Fig. 2C) 
compared with DSS+Veh-PCC mice. For histological analysis, 
segments of distal colons were embedded in paraffin and stained 
with periodic acid‐Schiff to observe goblet cells and mucins. 
We found that mucin levels were significantly increased in suc-
cinate-treated PCC group compared with DSS+Veh-PCC group 
(Fig. 3). Taken together, these results suggest that succinate-
treated PCC attenuates DSS-induced colitis. 
Although some researches on succinate have mainly describ ed 
succinate as a pro-inflammatory factor in many inflammatory 
diseases,8 there are contradictory studies that succinate acts 
as an anti-inflammatory factor.9,10 The succinate secreted by 
the cancer cells into their microenvironment induces polar-
ization into tumor-associated macrophages through SUCNR1 
signaling of macrophages.9 Besides, another study showed 
Fig. 1. Peritoneal cavity cell transfer in a dextran sulfate sodium (DSS)-colitis model. (A) Experimental design of the peritoneal cavity cells 
(PCCs) transfer. Donor mice were intraperitoneally injected with 40 mM succinate or not for 3 days. Recipient mice were transferred with 
the PCCs on day 0, were then administrated 2% DSS in drinking water until day 6 followed by normal water for 2 days and were sacri-
ficed on day 8. (B, C) Gating strategy of peritoneal macrophage sorting. F4/80+ PCCs isolation using BD FACS Aria II. (B) Unstained PCCs. 
(C) Stained pre-sorting PCCs and post-sorting PCCs. HBSS, Hanks’ balanced salt solution; Veh, vehicle; Suc, succinate; SSC-A, side-scatter 
area; FSC-A, forward-scatter area; FSC-W, forward-scatter width; FSC-H, forward-scatter height; SSC-W, side-scatter width; SSC-H, side-
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that SUCNR1 on macrophages plays a role in inducing anti-
inflammatory phenotype and limiting inflammation.10 These 
controversial results showing pro- and anti-inflammatory ef-
fects of succinate might be due to the complexity of the im-
mune system. In this study, we addressed the protective func-
tion of succinate in macrophages. 
It is well known that succinate dehydrogenase is impaired 
in inflammatory conditions, and then succinate is accumulat-
ed. Further studies investigating the effects of succinate on 
various macrophages types, using cell lines and primary cells 
from Sucnr1-/- mice would be warranted.
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Fig. 2. Transferred succinate-treated peritoneal cavity cells (Suc-PCCs) ameliorate dextran sulfate sodium (DSS)-induced colitis. The re-
cipients of Suc-PCCs show the attenuated body weight change (A), disease activity index (DAI) (B), and colon length (C) compared to ve-
hicle-treated PCC (Veh-PCC). The results were examined using Prism 5.0 software (GraphPad Inc.). Statistical significance was evaluated 
using one-way analysis of variance and P<0.05 were regarded to be significant. Bars in graphs represent mean±standard error of the 
mean. aP<0.05, bP<0.01, and cP<0.001 compared with the water group. dP<0.05, eP<0.01, and fP<0.001 compared with the Suc-PCC 
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Fig. 3. Periodic acid Schiff staining and quantification of colitis. (A) Section from colon tissues stained with periodic acid Schiff. Histo-
pathologic scores (B) and quantification with integrated density (IntDen) of goblet cells (C) of colon tissues from mice were assessed by 
Image J v.1.496 software (National Institutes of Health). The results were examined using Prism 5.0 software (GraphPad Inc.). Statistical 
significance was evaluated using one-way analysis of variance and t-test, respectively, P<0.05 were considered significant. Bars in graphs 
represent mean±standard error of the mean. aP<0.05, bP<0.001 compared with the water group in (B). DSS, dextran sulfate sodium; HBSS, 
Hanks’ balanced salt solution; PCC, peritoneal cavity cell; Veh, vehicle; Suc, succinate.
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